BR0012908A - Método para preparar uma composição oral estável antibacteriana contendo uma lupulona hidrogenada, e, composição oral estável antibacteriana - Google Patents

Método para preparar uma composição oral estável antibacteriana contendo uma lupulona hidrogenada, e, composição oral estável antibacteriana

Info

Publication number
BR0012908A
BR0012908A BR0012908-9A BR0012908A BR0012908A BR 0012908 A BR0012908 A BR 0012908A BR 0012908 A BR0012908 A BR 0012908A BR 0012908 A BR0012908 A BR 0012908A
Authority
BR
Brazil
Prior art keywords
oral composition
stable oral
antibacterial
preparing
antibacterial stable
Prior art date
Application number
BR0012908-9A
Other languages
English (en)
Inventor
Prem K Sreenivasan
Nuran Nabi
Abdul Gaffar
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of BR0012908A publication Critical patent/BR0012908A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

"MéTODO PARA PREPARAR UMA COMPOSIçãO ORAL ESTáVEL ANTIBACTERIANA CONTENDO UMA LUPULONA HIDROGENADA, E, COMPOSIçãO ORAL ESTáVEL ANTIBACTERIANA". Uma composição oral antibacteriana estável contendo lupulona hidrogenada e um agente tensoativo aniónico.
BR0012908-9A 1999-08-04 2000-08-01 Método para preparar uma composição oral estável antibacteriana contendo uma lupulona hidrogenada, e, composição oral estável antibacteriana BR0012908A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/366,892 US6129907A (en) 1999-08-04 1999-08-04 Stable hydrogenated lupulone antibacterial oral compositions
PCT/US2000/020967 WO2001010401A1 (en) 1999-08-04 2000-08-01 Stable hydrogenated lupulone antibacterial oral compositions

Publications (1)

Publication Number Publication Date
BR0012908A true BR0012908A (pt) 2002-04-30

Family

ID=23445030

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0012908-9A BR0012908A (pt) 1999-08-04 2000-08-01 Método para preparar uma composição oral estável antibacteriana contendo uma lupulona hidrogenada, e, composição oral estável antibacteriana

Country Status (15)

Country Link
US (1) US6129907A (pt)
EP (1) EP1200053B1 (pt)
JP (1) JP2003506392A (pt)
CN (1) CN1195483C (pt)
AR (1) AR025051A1 (pt)
AT (1) ATE313315T1 (pt)
AU (1) AU774885B2 (pt)
BR (1) BR0012908A (pt)
CA (1) CA2378587A1 (pt)
CO (1) CO5180575A1 (pt)
DE (1) DE60025000D1 (pt)
MX (1) MXPA02001076A (pt)
MY (1) MY122704A (pt)
WO (1) WO2001010401A1 (pt)
ZA (1) ZA200200620B (pt)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6475537B1 (en) 2000-07-27 2002-11-05 Rhodia Inc. Hops acid antibacterial compositions
DK1363510T3 (da) * 2001-03-02 2007-09-10 Kalsec Inc Labiatae urteetkstrakter og humleekstrakter til at forlænge farveholdbarheden og inhibering af væksten af mikroorganismer i frisk köd, fisk og fjerkræ
US7901714B2 (en) * 2001-06-20 2011-03-08 Metaproteomics, Llp Treatment modalities for autoimmune diseases
US7815944B2 (en) * 2001-06-20 2010-10-19 Metaproteomics, Llc Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment of prevention of gastric toxicity
US7718198B2 (en) * 2001-06-20 2010-05-18 Metaproteomics, Llc Treatment modalities for autoimmune diseases
US7901713B2 (en) * 2001-06-20 2011-03-08 Metaproteomics, Llc Inhibition of COX-2 and/or 5-LOX activity by fractions isolated or derived from hops
US7270835B2 (en) * 2001-06-20 2007-09-18 Metaproteomics, Llc Compositions that treat or inhibit pathological conditions associated with inflammatory response
US20040115290A1 (en) 2001-06-20 2004-06-17 Tripp Matthew L. Modulation of inflammation by hops fractions and derivatives
US8168234B2 (en) * 2001-06-20 2012-05-01 Metaproteomics, Llc Compositions that treat or inhibit pathological conditions associated with inflammatory response
US7205151B2 (en) * 2001-06-20 2007-04-17 Metaproteomics, Llc Complex mixtures exhibiting selective inhibition of cyclooxygenase-2
US20040219240A1 (en) * 2001-06-20 2004-11-04 Babish John G. Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity
US8206753B2 (en) * 2001-06-20 2012-06-26 Metaproteomics, Llc Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes
US8142819B2 (en) 2002-10-21 2012-03-27 Metaproteomics, Llc Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response
US20090263522A1 (en) * 2001-10-26 2009-10-22 Babish John G Curcuminoid Compositions Exhibiting Synergistic Inhibition Of The Expression And/Or Activity Of Cyclooxygenase-2
US7279185B2 (en) * 2001-10-26 2007-10-09 Metaproteonics, Llc Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2
US8158160B2 (en) 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors
BRPI0309918B8 (pt) * 2002-05-17 2022-11-22 Steiner Inc S S aplicação aperfeiçoada para ácidos de lúpulo como agentes antimicrobianos
US20030228814A1 (en) * 2002-06-07 2003-12-11 Barney Michael C. Antibacterial packaging material including hop acids
EP1558271A4 (en) * 2002-10-21 2006-01-11 Metaproteomics Llc COMPOSITIONS FOR TREATING OR INHIBITING PATHOLOGICAL CONDITIONS IN CONNECTION WITH AN INFLAMMATORY ANSWER
US7811610B2 (en) * 2003-05-22 2010-10-12 Metaproteomics, Llc Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity
WO2005089104A2 (en) * 2004-02-23 2005-09-29 Segal, Janet Feeds containing hop acids and uses thereof as supplements in animal feeds
US7914831B2 (en) 2004-02-27 2011-03-29 Metaproteomics, Llc Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines
US20050192356A1 (en) * 2004-02-27 2005-09-01 Babish John G. Synergistic anti-inflammatory pharmaceutical compositions and methods of use
EP2263663A1 (en) * 2004-11-13 2010-12-22 Metaproteomics, LLC Compositions comprising curcuminoids and either alpha or beta acids for use in the treatment of diabetes
US8900644B2 (en) * 2004-12-22 2014-12-02 Colgate-Palmolive Company Oral care compositions containing compounds from magnolia and hops extracts
GB0514943D0 (en) * 2005-07-20 2005-08-24 Botan Ltd Oral care compositions
JP2009504657A (ja) * 2005-08-09 2009-02-05 メタプロテオミクス，エルエルシー ホップ及びアカシア産物によるプロテインキナーゼ調節
AU2006321727A1 (en) * 2005-12-09 2007-06-14 Metaproteomics, Llc Protein kinase modulation by hops and Acacia products
TW200817023A (en) * 2006-06-20 2008-04-16 Metaproteomics Llc Xanthohumol based protein kinase modulation cancer treatment
EP2626077A3 (en) * 2007-03-19 2013-11-20 Metaproteomics, LLC Compositions for promoting bone and joint health
US8241674B2 (en) * 2007-05-11 2012-08-14 Metaproteomics, Llc Methods and compositions for heavy metal detoxification
WO2009076428A1 (en) * 2007-12-10 2009-06-18 Metaproteomics, Llc Substituted 1,3-cyclopentadione multi-target protein kinase modulators of cancer, angiogenesis and the inflammatory pathways associated therewith
KR20110010603A (ko) * 2008-04-02 2011-02-01 메타프로테오믹스, 엘엘씨 치환된 1,3-시클로펜타디온 약독화 내피 염증 및 내피-모노사이트 상호작용
MX2014008336A (es) 2014-07-07 2016-01-07 Pptm Internat S A R L Combinacion farmacologica antihiperalgesica, antialodinica y antiinflamatoria, composiciones farmaceuticas que la contienen, y su uso para el tratamiento del dolor neuropatico.
WO2021067993A1 (en) * 2019-09-30 2021-04-08 The Procter & Gamble Company Oral care compositions comprising hops beta acid and fluoride
WO2021062607A1 (en) 2019-09-30 2021-04-08 The Procter & Gamble Company Oral care compositions comprising hops beta acid and amino acid
MX2022003756A (es) * 2019-09-30 2022-05-03 Procter & Gamble Composiciones para el cuidado bucal que comprenden acido beta de lupulo e ion metalico.
EP4216908A1 (en) * 2020-09-28 2023-08-02 The Procter & Gamble Company Array of anticavity oral care compositions
US20220096363A1 (en) * 2020-09-28 2022-03-31 The Procter & Gamble Company Oral Care Composition Comprising Hops And Flavor
EP4734939A2 (en) * 2023-06-28 2026-05-06 The Procter & Gamble Company Oral care compositions comprising hops beta acids

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3486906A (en) * 1965-03-01 1969-12-30 Kalamazoo Spice Extract Co Water-dispersible hop flavors for malt beverages and the like
US3451821A (en) * 1965-03-01 1969-06-24 Kalamazoo Spice Extract Co Increasing the utilization of hops and improving flavor control of malt beverages and the like
US3615660A (en) * 1969-06-11 1971-10-26 Pfizer Hop extract emulsion and preparation and use thereof
US3932603A (en) * 1971-05-28 1976-01-13 General Foods Corporation Oral preparations for reducing the incidence of dental caries
US4894220A (en) * 1987-01-30 1990-01-16 Colgate-Palmolive Company Antibacterial antiplaque oral composition
US5032386A (en) * 1988-12-29 1991-07-16 Colgate-Palmolive Company Antiplaque antibacterial oral composition
US5334375A (en) * 1988-12-29 1994-08-02 Colgate Palmolive Company Antibacterial antiplaque oral composition
US5370863A (en) * 1992-12-16 1994-12-06 Miller Brewing Company Oral care compositions containing hop acids and method
US5690911A (en) * 1996-06-07 1997-11-25 Colgate Palmolive Company Oral composition containing a mixed surfactant system for promoting antibacterial compound uptake on dental tissue
US5800803A (en) * 1997-02-10 1998-09-01 Colgate-Palmolive Company Oral composition exhibiting enhanced uptake by dental tissue of noncationic antibacterial agents
US6165447A (en) * 1999-06-15 2000-12-26 Colgate-Palmolive Company Synergistic antibacterial combination

Also Published As

Publication number Publication date
WO2001010401A1 (en) 2001-02-15
CA2378587A1 (en) 2001-02-15
JP2003506392A (ja) 2003-02-18
MXPA02001076A (es) 2002-08-20
CN1377253A (zh) 2002-10-30
AU774885B2 (en) 2004-07-08
CO5180575A1 (es) 2002-07-30
US6129907A (en) 2000-10-10
ZA200200620B (en) 2003-06-25
ATE313315T1 (de) 2006-01-15
EP1200053B1 (en) 2005-12-21
DE60025000D1 (de) 2006-01-26
AR025051A1 (es) 2002-11-06
EP1200053A1 (en) 2002-05-02
MY122704A (en) 2006-04-29
AU6753100A (en) 2001-03-05
CN1195483C (zh) 2005-04-06

Similar Documents

Publication Publication Date Title
MY122704A (en) Stable hydrogenated lupulone antibacterial oral compositions
NO971192D0 (no) Fremgangsmåter for avlevering av materialer inn i huden, og sammensetninger som blir anvendt
YU22399A (sh) Čvrsti farmaceutski sastavi koji obuhvataju ciklosporin i anjonsko površinski-aktivno sredstvo
ES2109895T1 (es) Producto y procedimiento para el teñido oxidativo de fibras de queratina.
ES2176700T3 (es) Composiciones para la piel.
AP2001002225A0 (en) 1-heterocycle substituted diarylamines.
DK0700284T3 (da) Oxybutyninformuleringer med kontrolleret frigivelse
EP1072254A4 (en) FOOD, ORAL COMPOSITIONS AND MEDICAL COMPOSITIONS FOR PREVENTING OR TREATING PERIODONTOSIS AND PROCESS FOR PREVENTING OR TREATING PERIODONTOSIS
BR0215405A (pt) Composições e processos de uso de collajolie
UY24436A1 (es) Formulaciones orales de paroxetina de liberación controlada y retardada
ES2164842T3 (es) Procedimiento para la preparacion de composiciones de microcapsulas.
AR023529A1 (es) Una composicion champu acondicionadora del cabello y un metodo para acondicionar el cabello
BR9703302A (pt) Aparelho e método para a geração e uso de ìons férricos
WO2001068043A3 (fr) Compositions pour la teinture des fibres keratiniques contenant des derives de paraphenylenediamine a groupement pyrrolidinyle
PT1089704E (pt) Locao tricologica para aplicacao topica
SI1121127T1 (en) Oral pharmaceutical compositions containing buprenorphin
BRPI0209619B8 (pt) agente promotor de crescimento capilar
ES2191417T3 (es) Composicion desinfectante.
DE60003943D1 (de) Trimegestone enthaltende pharmazeutische zusammensetzungen
ATE268175T1 (de) Decursin-enthaltende pharmazeutische zusammensetzungen
AU2001269252A1 (en) Alcohol-free base for aqueous perfume composition, and alcohol-free aqueous perfume composition comprising same
ES2150404T1 (es) Composiciones farmaceuticas de tizoxanida y nitozoxanida.
IL128500A (en) SUBSTITUTED 1,2,3,4-TETRAHYDRO-2-DIBENZOFURANAMINES AND 2-AMINOCYCLOHEPTA[b] BENZOFURANS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
IT1318962B1 (it) Procedimento per l'invio di messaggi pubblicitari direttamente adutenti.
BR0314371A (pt) Composição para tingimento temporário de cabelos

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008.

B15K Others concerning applications: alteration of classification

Ipc: A61Q 11/00 (2006.01), A61K 8/34 (2006.01)